Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added revision note for v3.4.3 and removed the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-06T19:04:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions section. A new page revision tag shows Revision: v3.4.2 (replacing v3.4.1).
    Difference
    0.1%
    Check dated 2026-02-13T07:44:00.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now lists Primary Peritoneal Carcinoma and adds a resource link to the Genetic and Rare Diseases Information Center. The site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-05T14:20:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary toggle text added; metadata labels updated (Last Update Submitted that Met QC Criteria, No FEAR Act data) and Revision: v3.4.0, replacing the previous lowercase variants and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T07:32:38.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The Study Record Dates section changes from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This update is limited to a labeling change and does not modify any study data or core content.
    Difference
    0.1%
    Check dated 2026-01-22T05:22:53.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.4, replacing Revision: v3.3.3, which is an internal revision update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:44:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.